Trevi Therapeutics, Inc.TRVINASDAQ
Loading
Asset Growth AcceleratingAccelerating
Percentile Rank67
3Y CAGR-30.3%
Studio
Year-over-Year Change

Year-over-year total asset growth rate

3Y CAGR
-30.3%/yr
Annual compound
Percentile
P67
Within normal range
vs 3Y Ago
0.3x
Contraction
Streak
2 yr
Consecutive growthAccelerating
PeriodValue
202574.43%
202424.05%
2023-27.32%
2022219.73%
2021-18.37%
2020-21.45%
2019192.84%
2018-7.82%
2017164.34%
20160.00%